What Is Driving Global Ventral Hernia Treatment Market Growth in 2025: The Role of Impact Of Rising Obesity Rates On The Growth Of The Ventral Hernia Treatment Market

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Ventral Hernia Treatment Market Size Growth Forecast: What to Expect by 2025?
The expansion of the ventral hernia treatment sector has been robust over the past several years, projecting a rise from a valuation of $4.87 billion in 2024 to $5.22 billion in 2025, reflecting a steady compound annual growth rate of 7.2%; this upward trajectory during the historical timeframe is linked to several factors, including the escalating incidence of obesity, heightened public understanding regarding ventral hernias, the expanding proportion of older individuals in the population, augmentation in personal disposable income, and a greater inclination towards less invasive surgical interventions.

How Will the Ventral Hernia Treatment Market Size Evolve and Grow by 2029?
Projection models indicate that the market dedicated to treating ventral hernias anticipates substantial expansion in the approaching years, reaching a valuation of $6.84 billion by 2029, propelled by a compound annual growth rate (CAGR) of 7.0%; this anticipated rise throughout the forecast timeframe is fundamentally linked to several factors, such as the escalating preference for procedures performed in ambulatory settings, increased overall healthcare expenditure, the proliferation of governmental support programs, a growing necessity for hernia correction operations, and heightened capital allocation toward inventive research and development activities, while key developments shaping the market over this period encompass the introduction of sophisticated hernia mending apparatuses, the adoption of materials that naturally dissolve, the formation of calculated alliances, the deployment of surgically assisted tools guided by robotics, and the implementation of distanced patient surveillance systems.

View the full report here:
https://www.thebusinessresearchcompany.com/report/ventral-hernia-treatment-global-market-report

What Drivers Are Propelling the Growth of Ventral Hernia Treatment Market Forward?
The escalating incidence of obesity is anticipated to fuel the expansion of the market for ventral hernia treatment in the foreseeable future. Obesity, defined as an unhealthy accumulation of body fat, adversely affects an individual's well-being, stemming from factors like suboptimal nutrition, inactivity, hereditary predispositions, insufficient exercise, environmental pressures, and psychological strain. Treatments for ventral hernias benefit those affected by obesity by managing associated complications, specifically by lessening the tension on the abdominal area, minimizing the likelihood of the hernia returning, and bolstering core muscularity, which is vital for improving movement and fostering better health habits among the obese population. To illustrate this trend, the World Health Organization, headquartered in Switzerland, released statistics in March 2024 indicating that roughly one in every eight persons globally contended with obesity; this figure comprised 2.5 billion adults (aged eighteen and above) classified as overweight, with 890 million of those individuals classified as having obesity, translating to 43% of adults being overweight and 16% being obese; furthermore, among toddlers under five, 37 million were found to be overweight. Consequently, the growing frequency of obesity serves as a significant driver for the ventral hernia treatment sector.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21315&type=smp

Which Emerging Trends Are Transforming the Ventral Hernia Treatment Market in 2025?
Key players within the ventral hernia treatment sector are prioritizing innovations in technology, specifically regarding devices for affixing mesh in both laparoscopic and open surgical procedures, aiming to elevate the success rates of operations, minimize adverse events, and accelerate patient recuperation. These fixation implements, utilized in both non-invasive (laparoscopic) and conventional open surgery to secure the mesh during hernia mending, represent the focus of these advancements. As an illustration, in March of 2024, TELA Bio Inc., an American firm specializing in medical technology, introduced its LIQUIFIX FIX8 for laparoscopic use and the LIQUIFIX precision devices intended for open hernia mesh fixation across the United States; the former is designed for minimally invasive corrections, whereas the latter targets open femoral and inguinal hernia repairs. Because these systems have received clearance from the FDA, they employ liquid anchoring mechanisms allowing mesh attachment without puncturing surrounding tissue, thereby lessening trauma and mitigating potential complications; considering the volume of more than 1.2 million hernia operations performed annually in the US, the LIQUIFIX system provides both accuracy and security, particularly in delicate regions, while simultaneously decreasing the probability of damage to nerves or blood vessels.

What Are the Key Segments in the Ventral Hernia Treatment Market?
The ventral hernia treatmentmarket covered in this report is segmented -

1) By Type: Epigastric (Stomach Area) Hernia; Umbilical (Belly Button) Hernia; Incisional Hernia
2) By Diagnosis: Ultrasound; Computed Tomography (CT) Scan; Magnetic Resonance Imaging (MRI)
3) By Surgery: Open Hernia Surgery; Laparoscopic Surgery; Robotic Hernia Surgery
4) By End Users: Hospitals; Ambulatory Surgical Centres; Clinics

Subsegments:
1) By Epigastric (Stomach Area) Hernia: Small Epigastric Hernia; Large Epigastric Hernia
2) By Umbilical (Belly Button) Hernia: Congenital Umbilical Hernia; Acquired Umbilical Hernia
3) By Incisional Hernia: Primary Incisional Hernia; Recurrent Incisional Hernia

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=21315&type=smp

Who Are the Key Players Shaping the Ventral Hernia Treatment Market's Competitive Landscape?
Major companies operating in the ventral hernia treatment market are Johnson And Johnson Services Inc., AbbVie, Abbott Laboratories, Medtronic Plc, Becton, dic*kinson and Company (BD), Baxter International Inc., Braun Melsungen AG, Zimmer Biomet, Olympus Corporation, W.L. Gore and Associates Inc, STERIS Plc, Cook Medical Inc., KARL STORZ, Cooper University Health Care, Mölnlycke Health Care, Integra LifeSciences Holdings, ConMed Corporation, Aesculap Inc, Richard Wolf GmbH, Ethicon Inc, Tela Bio, Microline Surgical, Hernia Mesh S.R.L., Insightra Medical Inc, Advanced MedTech Solutions Pvt Ltd.

What Geographic Markets Are Powering Growth in the Ventral Hernia Treatment Market?
North America was the largest region in the ventral hernia treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the ventral hernia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21315

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.